Home
IUCT Oncopole

IUCT Oncopole Market Share Analysis for November 2025

Health > Health Conditions and Concerns

Domainiuct-oncopole.fr

Year Founded1923

Employees1001 - 5000

Annual Revenue$100M - $200M

IUCT Oncopole

IUCT Oncopole (including company regionals)

iuct-oncopole.fr

See more website traffic and engagement information

IUCT Oncopole Revenue up to November 2025 is 100M - 200M

revenue generated by IUCT Oncopole top domains

IUCT Oncopole top domains revenue over 3 years

Revenue for IUCT Oncopole top domains

iuct-oncopole.fr100M - 200M

See more with Sales Intelligence

Total visits to IUCT Oncopole's top domains

Understand IUCT Oncopole market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

iuct-oncopole.fr15.2K

See more with Sales Intelligence

Avg. visit duration in IUCT Oncopole's top domains

Analyze IUCT Oncopole engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

iuct-oncopole.fr00:01:51

See more with Sales Intelligence

Avg. pageviews on IUCT Oncopole's top domains

See how IUCT Oncopole keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

iuct-oncopole.fr4.18

See more with Sales Intelligence

IUCT Oncopole top competitors by domain

Top similar sites in November 2025, ranked by their affinity

crct-inserm.frCompany NamePrivacy policy - Toulouse Cancer Rese...Employees201 - 500HQFrance, ToulouseAnnual revenue--Total visits3.6KHealth > Health Conditions and Concerns

Top technologies used by IUCT Oncopole

These are the website technologies, by industry, used by IUCT Oncopole top domains

Social (9)

Google+ Platform

Advertising (3)

Google Adsense

Audio Video Media (2)

YouTube

Content Management System (1)

Liferay

More Technologies

4

See all

News & Signals from IUCT Oncopole

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIuct Oncopole partners with Cell-Easy SAS.By collaborating with Cell-Easy, a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of cutting-edge cell and gene therapy products, IUCT-Oncopole is taking a significant step forward in their commitment to advancing healthcare and improving patient outcomes.

NewsIuct Oncopole launches ambitious national project.The IUCT-Oncopole is launching an ambitious national project in collaboration with Artios Pharma Limited (Artios), a clinical stage biotech company pioneering the development of novel small molecule therapeutics that target the DNA damage response (“DDR”) process to unravel the mechanisms of resistance to anti-PARP therapies in patients with metastatic breast cancer with germline mutations of the BRCA1 and/or 2 genes.